The new rules will fast track clinical testing, but a far cry from legalization or decriminalization.
Trump Speeds Up Access to Psychedelic PTSD Treatments
President Trump signs executive order to expedite FDA review of psychedelic drugs for treating veterans' mental health conditions, including PTSD and depression.
Psychedelics have genuine potential as psychiatric tools, which is why separating them from politics is so important. IF YOU DON’T LIKE ROBERT F. KENNEDY JR. setting national health policy, how do yo...
It has been six days since President Donald Trump signed an executive order aimed at facilitating regulatory review of psychedelics that have shown potential as psychotherapeutic catalysts. As promise...
The Food and Drug Administration announced on Friday a series of actions intended to accelerate the use of psychedelic treatments for serious mental illness, including fast-tracking research for appro...
On Saturday, President Donald Trump issued an executive order aimed at "accelerating medical treatments for serious mental illness" by facilitating regulatory approval of ibogaine and other psychedeli...
This is the way the drug war starts to end, not with a bang or a whimper, but with an executive order signed by a president who must surely be the least-psychedelic occupant ever of the Oval Office, e...
In a significant move, President Trump's executive order aims to expedite research and access to psychedelic therapeutics, with the FDA Commissioner Marty McCary detailing the new measures. The order...
The president's facilitation of research and FDA review could help make psychedelics available to approved patients. But what about everyone else?
VIRAL MOMENT: Trump Asks If He Can 'Have Some' Ibogaine–A Psychedelic Drug—During Press Briefing
Psychedelics getting Trump sign off. Been holding Atai, Mindmed and Compass pathways for a while now (yes, they are up a lot but too small to post about). What goes up keeps going up when these assist...
President Trump signed an executive order on Saturday calling for the acceleration of research on certain psychedelic drugs as treatments for depression and other conditions. Podcaster Joe Rogan stood...
In a press briefing, President Trump expressed interest in trying Ibogaine, a psychedelic drug, citing a 2024 Stanford University study that reported an 80 to 90% reduction in symptoms of depression a...
President Donald Trump signed an executive order allowing the use of some psychedelic drugs to treat post-traumatic stress disorder. Flanked by Health and Human Services Secretary Robert F. Kennedy J...
President Donald Trump on Saturday signed a sweeping executive order aimed at fast-tracking access to psychedelic-based treatments for veterans suffering from PTSD, depression, and other severe mental...
